UNITEDHEALTH GROUP INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that UNITEDHEALTH GROUP INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $447.57B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $400.28B | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $371.62B | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $324.16B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $287.60B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $257.14B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $242.16B | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $226.25B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $201.16B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $184.84B | Feb 12, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.06B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $14.41B | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $22.38B | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $20.12B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $17.29B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $15.40B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $13.84B | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $11.99B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $10.56B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $7.02B | Feb 12, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.96B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $32.29B | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $32.36B | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $28.44B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $23.97B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $22.41B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $19.69B | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $17.34B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $15.21B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $12.93B | Feb 12, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $59.59B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $53.01B | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $54.63B | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $47.78B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $42.58B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $41.70B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $35.19B | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $34.07B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $29.56B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $28.40B | Feb 12, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.70B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $24.20B | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $29.07B | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $26.21B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $22.34B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $22.17B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $18.46B | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $15.71B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $13.60B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $9.80B | Feb 12, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.62B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $3.50B | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $3.39B | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $2.80B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.45B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $2.05B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $2.07B | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $2.06B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $2.02B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $1.71B | Feb 12, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $309.58B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $298.28B | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $273.72B | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $245.71B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $212.21B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $197.29B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $173.89B | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $152.22B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $139.06B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $122.81B | Feb 12, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $207.88B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $195.69B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $174.80B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $159.36B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $135.73B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $126.75B | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $111.73B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $95.99B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $87.04B | Feb 12, 2019 |
| FY2017 | Dec 31, 2016 | $82.62B | Feb 13, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $32.45B | Feb 10, 2015 |
| FY2014 | Dec 31, 2013 | $32.15B | Feb 10, 2015 |
| FY2014 | Dec 31, 2012 | $31.18B | Feb 10, 2015 |
| FY2014 | Dec 31, 2011 | $28.29B | Feb 10, 2015 |
| FY2012 | Dec 31, 2010 | $25.83B | Feb 7, 2013 |
| FY2012 | Dec 31, 2009 | $23.61B | Feb 7, 2013 |
| FY2011 | Dec 31, 2008 | $20.78B | Feb 9, 2012 |
| FY2010 | Dec 31, 2007 | $20.06B | Feb 10, 2011 |
| FY2009 | Dec 31, 2006 | $20.81B | Feb 10, 2010 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $110.50B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $106.73B | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $103.73B | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $93.35B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $75.80B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $71.34B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $65.66B | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $58.91B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $54.56B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $47.58B | Feb 12, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $95.60B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $96.04B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $95.77B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $86.16B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $77.13B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $69.30B | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $61.18B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $55.85B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $48.73B | Feb 12, 2019 |
| FY2017 | Dec 31, 2016 | $40.95B | Feb 13, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.37B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $25.31B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $25.43B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $23.37B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $21.38B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $16.92B | Feb 15, 2022 |
| FY2021 | Dec 31, 2019 | $10.99B | Feb 15, 2022 |
| FY2021 | Dec 31, 2018 | $10.87B | Feb 15, 2022 |
| FY2020 | Dec 31, 2017 | $11.98B | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | $10.43B | Feb 14, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 15 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 24 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 21 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 18 | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | 16 | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | 14 | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | 12 | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | 10 | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | 7 | Feb 12, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 15 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 23 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 21 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 18 | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | 16 | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | 14 | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | 12 | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | 10 | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | 7 | Feb 12, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 906.00M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 915.00M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | 924.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 934.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 941.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | 946.00M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | 948.00M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 960.00M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | 969.00M | Feb 12, 2019 |
| FY2017 | Dec 31, 2016 | 952.00M | Feb 13, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.92B | Mar 2, 2026 |
| FY2025 | Dec 16, 2025 | $2.00B | Mar 2, 2026 |
| FY2025 | Sep 23, 2025 | $2.00B | Mar 2, 2026 |
| FY2025 | Jun 24, 2025 | $2.00B | Mar 2, 2026 |
| FY2025 | Mar 18, 2025 | $1.91B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $7.53B | Mar 2, 2026 |
| FY2024 | Dec 17, 2024 | $1.93B | Feb 27, 2025 |
| FY2024 | Sep 24, 2024 | $1.94B | Feb 27, 2025 |
| FY2024 | Jun 25, 2024 | $1.94B | Feb 27, 2025 |
| FY2024 | Mar 19, 2024 | $1.73B | Feb 27, 2025 |